119 related articles for article (PubMed ID: 24685603)
1. Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-analysis.
Wang J; Shi D; Guo X; Zhang J; Yu S; Song J; Cao Z; Wang J; Ji M; Dong W
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):481-90. PubMed ID: 24685603
[TBL] [Abstract][Full Text] [Related]
2. The association between two polymorphisms in the TS gene and risk of cancer: a systematic review and pooled analysis.
Zhou JY; Shi R; Yu HL; Zeng Y; Zheng WL; Ma WL
Int J Cancer; 2012 Nov; 131(9):2103-16. PubMed ID: 22307944
[TBL] [Abstract][Full Text] [Related]
3. [Frequency of TS1494del6 polymorphism in colorectal patients from west of Mexico].
Gallegos-Arreola MP; Peralta-Leal V; Morgan-Villela G; Puebla-Pérez AM
Rev Invest Clin; 2008; 60(1):21-30. PubMed ID: 18589584
[TBL] [Abstract][Full Text] [Related]
4. 3R variant of thymidylate synthase 5'-untranslated enhanced region contributes to colorectal cancer risk: a meta-analysis.
Lu M; Sun L; Yang J; Li YY
Asian Pac J Cancer Prev; 2012; 13(6):2605-10. PubMed ID: 22938428
[TBL] [Abstract][Full Text] [Related]
5. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
[TBL] [Abstract][Full Text] [Related]
6. Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.
Adleff V; Hitre E; Köves I; Orosz Z; Hajnal A; Kralovánszky J
Int J Cancer; 2004 Mar; 108(6):852-6. PubMed ID: 14712487
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase T1 gene polymorphism and colorectal cancer risk: an updated analysis.
Qin XP; Zhou Y; Chen Y; Li NN; Chen B; Yang P; Wu XT
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):626-35. PubMed ID: 23773486
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer.
Chen J; Hunter DJ; Stampfer MJ; Kyte C; Chan W; Wetmur JG; Mosig R; Selhub J; Ma J
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):958-62. PubMed ID: 14578129
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Shi Q; Sturgis EM; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 2004 Dec; 10(23):7903-10. PubMed ID: 15585623
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase genetic polymorphisms and cancer risk: a meta-analysis of 37 case-control studies.
Tang J; Wang PP; Zhuang YY; Chen WJ; Huang FT; Zhang SN
Chin Med J (Engl); 2012 Jul; 125(14):2582-8. PubMed ID: 22882943
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase pharmacogenetics in colorectal cancer.
Marsh S; McLeod HL
Clin Colorectal Cancer; 2001 Nov; 1(3):175-8; discussion 179-81. PubMed ID: 12450432
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase gene polymorphisms and markers of DNA methylation capacity.
Ho V; Massey TE; King WD
Mol Genet Metab; 2011 Apr; 102(4):481-7. PubMed ID: 21269855
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis.
Xi B; Zeng T; Liu L; Liang Y; Liu W; Hu Y; Li J
Breast Cancer Res Treat; 2011 Nov; 130(2):561-8. PubMed ID: 21638051
[TBL] [Abstract][Full Text] [Related]
15. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
Rah H; Jeon YJ; Choi Y; Shim SH; Yoon TK; Choi DH; Cha SH; Kim NK
Menopause; 2012 Nov; 19(11):1260-6. PubMed ID: 22713864
[TBL] [Abstract][Full Text] [Related]
16. Influence of thymidylate synthase gene polymorphisms on total plasma homocysteine concentrations.
Ho V; Massey TE; King WD
Mol Genet Metab; 2010 Sep; 101(1):18-24. PubMed ID: 20580582
[TBL] [Abstract][Full Text] [Related]
17. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan.
Matsuo K; Ito H; Wakai K; Hirose K; Saito T; Suzuki T; Kato T; Hirai T; Kanemitsu Y; Hamajima H; Tajima K
Carcinogenesis; 2005 Dec; 26(12):2164-71. PubMed ID: 16051637
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population.
Nazki FH; Masood A; Banday MA; Bhat A; Ganai BA
Genet Mol Res; 2012 Apr; 11(2):906-17. PubMed ID: 22576918
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.
Tsuji T; Hidaka S; Sawai T; Nakagoe T; Yano H; Haseba M; Komatsu H; Shindou H; Fukuoka H; Yoshinaga M; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3700-4. PubMed ID: 14506161
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.
Zhang YM; Zhou XC; Xu Z; Tang CJ
Genet Mol Res; 2012 Sep; 11(3):3389-97. PubMed ID: 23079832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
